These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 17950620

  • 1. Expression, purification, and characterization of an immunotoxin containing a humanized anti-CD25 single-chain fragment variable antibody fused to a modified truncated Pseudomonas exotoxin A.
    Wang H, Dai J, Li B, Fan K, Peng L, Zhang D, Cao Z, Qian W, Wang H, Zhao J, Guo Y.
    Protein Expr Purif; 2008 Mar; 58(1):140-7. PubMed ID: 17950620
    [Abstract] [Full Text] [Related]

  • 2. Expression and purification of recombinant immunotoxin--a fusion protein stabilizes a single-chain Fv (scFv) in denaturing condition.
    Kim SH.
    Protein Expr Purif; 2003 Jan; 27(1):85-9. PubMed ID: 12509988
    [Abstract] [Full Text] [Related]

  • 3. [Studies of the expression, purification, renaturation and biologic activity of an anti-CEA immunotoxin].
    Yang H, He D, Chao K, Lin Q, You S, Huang HL.
    Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):348-51. PubMed ID: 15971603
    [Abstract] [Full Text] [Related]

  • 4. Expression, purification, and refolding of a novel immunotoxin containing humanized single-chain fragment variable antibody against CTLA4 and the N-terminal fragment of human perforin.
    Wan L, Zeng L, Chen L, Huang Q, Li S, Lu Y, Li Y, Cheng J, Lu X.
    Protein Expr Purif; 2006 Aug; 48(2):307-13. PubMed ID: 16584889
    [Abstract] [Full Text] [Related]

  • 5. Influence of relative binding affinity on efficacy in a panel of anti-CD3 scFv immunotoxins.
    Hexham JM, Dudas D, Hugo R, Thompson J, King V, Dowling C, Neville DM, Digan ME, Lake P.
    Mol Immunol; 2001 Sep; 38(5):397-408. PubMed ID: 11684296
    [Abstract] [Full Text] [Related]

  • 6. Soluble Cytoplasmic Expression and Purification of Immunotoxin HER2(scFv)-PE24B as a Maltose Binding Protein Fusion.
    Park S, Nguyen MQ, Ta HKK, Nguyen MT, Lee G, Kim CJ, Jang YJ, Choe H.
    Int J Mol Sci; 2021 Jun 17; 22(12):. PubMed ID: 34204265
    [Abstract] [Full Text] [Related]

  • 7. Construction and in vitro evaluation of RFT5(scFv)-ETA', a new recombinant single-chain immunotoxin with specific cytotoxicity toward CD25+ Hodgkin-derived cell lines.
    Barth S, Huhn M, Wels W, Diehl V, Engert A.
    Int J Mol Med; 1998 Jan 17; 1(1):249-56. PubMed ID: 9852227
    [Abstract] [Full Text] [Related]

  • 8. Cytotoxic and antitumor activity of a recombinant immunotoxin composed of disulfide-stabilized anti-Tac Fv fragment and truncated Pseudomonas exotoxin.
    Reiter Y, Kreitman RJ, Brinkmann U, Pastan I.
    Int J Cancer; 1994 Jul 01; 58(1):142-9. PubMed ID: 8014011
    [Abstract] [Full Text] [Related]

  • 9. Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systems.
    Della Cristina P, Castagna M, Lombardi A, Barison E, Tagliabue G, Ceriotti A, Koutris I, Di Leandro L, Giansanti F, Vago R, Ippoliti R, Flavell SU, Flavell DJ, Colombatti M, Fabbrini MS.
    Microb Cell Fact; 2015 Feb 13; 14():19. PubMed ID: 25889802
    [Abstract] [Full Text] [Related]

  • 10. [Soluble expression of recombinant immunotoxin against human bladder carcinoma and its anti-tumor activity].
    Chao K, He D, Yang H, Zhang Z, Lin Q, Guo AG, Huang HL.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep 13; 20(5):568-71. PubMed ID: 15367349
    [Abstract] [Full Text] [Related]

  • 11. Recombinant immunotoxins containing the VH or VL domain of monoclonal antibody B3 fused to Pseudomonas exotoxin.
    Brinkmann U, Lee BK, Pastan I.
    J Immunol; 1993 Apr 01; 150(7):2774-82. PubMed ID: 8454854
    [Abstract] [Full Text] [Related]

  • 12. Preparation and characterization of fusion protein truncated Pseudomonas Exotoxin A (PE38KDEL) in Escherichia coli.
    Song S, Xue J, Fan K, Kou G, Zhou Q, Wang H, Guo Y.
    Protein Expr Purif; 2005 Nov 01; 44(1):52-7. PubMed ID: 15922623
    [Abstract] [Full Text] [Related]

  • 13. A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies.
    Buchner J, Pastan I, Brinkmann U.
    Anal Biochem; 1992 Sep 01; 205(2):263-70. PubMed ID: 1332541
    [Abstract] [Full Text] [Related]

  • 14. Construction, expression, and characterization of an anti-tumor immunotoxin containing the human anti-c-Met single-chain antibody and PE38KDEL.
    Liu Z, Feng Z, Zhu X, Xu W, Zhu J, Zhang X, Fan Z, Ji G.
    Immunol Lett; 2013 Jan 01; 149(1-2):30-40. PubMed ID: 23026237
    [Abstract] [Full Text] [Related]

  • 15. Recombinant CD64-specific single chain immunotoxin exhibits specific cytotoxicity against acute myeloid leukemia cells.
    Tur MK, Huhn M, Thepen T, Stöcker M, Krohn R, Vogel S, Jost E, Osieka R, van de Winkel JG, Fischer R, Finnern R, Barth S.
    Cancer Res; 2003 Dec 01; 63(23):8414-9. PubMed ID: 14679004
    [Abstract] [Full Text] [Related]

  • 16. Recombinant immunotoxins for the treatment of Hodgkin's disease (Review).
    Matthey B, Engert A, Barth S.
    Int J Mol Med; 2000 Nov 01; 6(5):509-14. PubMed ID: 11029515
    [Abstract] [Full Text] [Related]

  • 17. Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragment.
    Reiter Y, Brinkmann U, Jung SH, Lee B, Kasprzyk PG, King CR, Pastan I.
    J Biol Chem; 1994 Jul 15; 269(28):18327-31. PubMed ID: 7913461
    [Abstract] [Full Text] [Related]

  • 18. In vivo efficacy of the recombinant anti-CD64 immunotoxin H22(scFv)-ETA' in a human acute myeloid leukemia xenograft tumor model.
    Tur MK, Huhn M, Jost E, Thepen T, Brümmendorf TH, Barth S.
    Int J Cancer; 2011 Sep 01; 129(5):1277-82. PubMed ID: 21077160
    [Abstract] [Full Text] [Related]

  • 19. A recombinant immunotoxin that is active on prostate cancer cells and that is composed of the Fv region of monoclonal antibody PR1 and a truncated form of Pseudomonas exotoxin.
    Brinkmann U, Gallo M, Brinkmann E, Kunwar S, Pastan I.
    Proc Natl Acad Sci U S A; 1993 Jan 15; 90(2):547-51. PubMed ID: 8421689
    [Abstract] [Full Text] [Related]

  • 20. Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopes.
    Onda M, Beers R, Xiang L, Lee B, Weldon JE, Kreitman RJ, Pastan I.
    Proc Natl Acad Sci U S A; 2011 Apr 05; 108(14):5742-7. PubMed ID: 21436054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.